NLRP3 and chronic obstructive pulmonary disease: Therefore, we proposed a scientific hypothesis: SchA plays a role in the treatment of COPD by regulating the Nrf2 pathway, accelerating the clearance of ROS in the lung, and inhibiting the activation of the NLRP3 inflammasome, thereby interfering with cell pyroptosis.